The InstituteThe Centre for Genomic Regulation (CRG) is an international biomedical research institute of excellence, based in Barcelona, Spain, with more than 400 scientists from 44 countries. The CRG is composed by an interdisciplinary, motivated and creative scientific team which is supported both by a flexible and efficient administration and by high-end and innovative technologies.In April 2021, the Centre for Genomic Regulation (CRG) received the renewal of the 'HR Excellence in Research' (https://www.crg.eu/en/content/careers/hr-excellence-research) Award from the European Commission. This is a recognition of the Institute's commitment to developing an HR Strategy for Researchers, designed to bring the practices and procedures in line with the principles of the European Charter for Researchers ( https://euraxess.ec.europa.eu/jobs/charter/european-charter) and the Code of Conduct for the Recruitment of Researchers (Charter and Code) ( https://euraxess.ec.europa.eu/jobs/charter/code).Please, check out our Recruitment Policy:https://www.crg.eu/sites/default/files/crg/crg_recruitment_policy.pdfThe UnitThe Proteomics Unit is a joint effort of the Universitat Pompeu Fabra and the Center of Genomic Regulation to create an innovative research infrastructure with a high-level of excellence and sustainability to support scientists in the biomedical field. The activities of the Proteomics Unit are focused onto the provision of high-quality proteomics services with strong added-value to the research community by i) offering state-of-the-art methods, advise and expertise to support basic and translational researchers; ii) developing new methods and techniques that keep the unit up to date and at the forefront of the proteomics field; and iii) training the community and actively disseminating proteomics science and methods.The Proteomics Unit is part of the Spanish National Infrastructure for Omics Technologies (ICTS OmicsTech) and the European Proteomics Infrastructure Consortium (EPIC-XS, GA 823839), and it coordinates the European innovative and interdisciplinary Research and Training network PROTrEIN (GA 956148). The Proteomics Unit is also part of the "Plataforma de Recursos Biomoleculares y Bioinformáticos - ProteoRed" of the Instituto de Salud Carlos III, part of the Spanish National Health System (PT17/0019 ).You can learn more about the unit by taking the virtual tour HERE.The roleA postdoctoral position is open at the CRG/UPF Proteomics Unit in Barcelona to work on the proteome characterization of model cell lines, primary cultures, and human biopsies from atopic dermatitis using nano-HPLC and mass spectrometry. The successful applicant will become a part of an international team of scientists, which is working closely with scientists at the Parc de Recerca Biomèdica de Barcelona.We are looking for highly motivated and organized candidates with previous experience in molecular biology, mass spectrometry, proteomics and similar analytical techniques. Candidates must have good communication skills, capable of working in a group, and with a high degree of work autonomy. The following aspects will be preferred and will be taken into account when selecting candidates:Professional experienceMust HaveEducation and trainingPhD in Chemistry, Biology, Pharmacy, Biochemistry or related disciplines.Technical skills requiredPrevious experience in mass spectrometry-based proteomics.Previous experience in proteomics sample preparation and data analysis.LanguagesFluent level of EnglishDesirable but not required/ Nice to havePrevious experience in proteomics.Analytical skills and critical thinking.Capability of working independently and in a team.Good skills with office automation and data analysis software.The Offer – Working ConditionsContract duration: Technical and scientific activities contract - estimated project duration 2 years.Estimated annual gross salary: Salary is commensurate with qualifications and consistent with our pay scales.Target start date: ASAP 2024We provide a highly stimulating environment with state-of-the-art infrastructures, and unique professional career development opportunities. To check out our training and development portfolio, please visit our website in the training section.( https://www.crg.eu/en/content/training).We offer and promote a diverse and inclusive environment and welcomes applicants regardless of age, disability, gender, nationality, ethnicity, religion, sexual orientation or gender identity.The CRG is committed to reconcile a work and family life of its employees and are offering extended vacation period and the possibility to benefit from flexible working hours.Application ProcedureAll applications must include:A motivation letter addressed to Dr Eduard Sabidó.A complete CV including contact details.Contact details of two referees.All applications must be addressed to Dr. Eduard Sabidó and be submitted online on the CRG Career site - http://www.crg.eu/en/content/careers/job-opportunitiesSelection ProcessPre-selection: The pre-selection process will be based on qualifications and expertise reflected on the candidates CVS. It will be merit-based.Interview: Preselected candidates will be interviewed by the Hiring Manager of the position and a selection panel if required.Offer Letter: Once the successful candidate is identified the Human Resources department will send a Job Offer, specifying the start day, salary, working conditions, among other important details.Deadline: Please submit your application by June 15, 2024Suggestions: The CRG believes in ongoing improvement and promotes a culture of feedback. This is one of the reasons we have in place, at your disposal as a candidate, a mechanism to gather your suggestions/complaints concerning your candidate experience in our recruitment processes. Your feedback really matters to us in our aim at creating a positive candidate journey. You can make a difference and help us improve by letting us know your suggestions through the following form. https://recruitment.crg.eu/webforms/recruitment-contact-form-suggestionscomplaintsEl presente contrato está financiado por el Instituto de Salud Carlos III con cargo a los fondos europeos del Plan de Recuperación, Transformación y Resiliencia, con código de expediente PMPTA23/00022, en virtud de Resolución de la Dirección del Instituto de Salud Carlos III, O.A., M.P. de 22 de diciembre de 2022, por la que se conceden subvenciones "Sello de Excelencia ISCIII-HEALTH", y "Financiado por la Unión Europea - NextGenerationEU#J-18808-Ljbffr
